Stone House Investment Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.76K Buy
763
+431
+130% +$2.31K ﹤0.01% 615
2026
Q1
$1.79K Buy
+332
New +$1.99K ﹤0.01% 611
2024
Q4
Sell
-1,500
Closed -$12.2K 82
2024
Q3
$12.2K Hold
1,500
﹤0.01% 211
2024
Q2
$10.5K Hold
1,500
﹤0.01% 220
2024
Q1
$15.9K Hold
1,500
﹤0.01% 203
2023
Q4
$12K Hold
1,500
﹤0.01% 152
2023
Q3
$12.3K Hold
1,500
﹤0.01% 150
2023
Q2
$12K Hold
1,500
﹤0.01% 146
2023
Q1
$12.2K Buy
+1,500
New +$12K ﹤0.01% 145

Other funds holding BHC

Stone House Investment Management's BHC Position: Q2 2026 in Review

Stone House Investment Management increased its Bausch Health (BHC) stake by 130% in Q2 2026, buying an estimated $2.31K and bringing the position to 763 shares worth $3.76K. The position accounts for ﹤0.01% of the portfolio, ranked #615.

Stone House Investment Management first reported a position in BHC in Q1 2023 and has held it in 9 quarters since. The position peaked at $15.9K in Q1 2024. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • Stone House Investment Management held 763 shares of Bausch Health worth $3.76K as of Q2 2026.
  • Stone House Investment Management bought 431 Bausch Health shares in Q2 2026, an estimated $2.31K.
  • Bausch Health made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #615 holding.
  • Stone House Investment Management first reported a position in Bausch Health in Q1 2023 and has held it in 9 quarters since.
  • Stone House Investment Management's Bausch Health position peaked at $15.9K in Q1 2024.
  • 222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.